How soon upon FDA approval and positive test results will a large drug company grab ACTC? These folks are not stupid you know. Their future revenues from drug products could be threatened substantially by stem cells. I would hope shareholders of ACTC would reject a buyout but I've come to believe that a few bucks thrown at some of these characters here would be all it would take.
OK, count me in partially as one of those characters. I'm averaged in currently just below .10 (OK amateur bashers run with that one). I have stated before that my initial target is 2-3 dollars. I will be selling a portion of my miniscule 135K shares at that point. No reasonable person would have a problem with that. Let's say that I sell half at $2.00, 67,500 X 2 = $135,000.00 + my remaining shares. Not too bad for my $13,000.00 investment.
I want this company to succeed as much as anyone.
That said, I would suggest that folks go back and look at some of the companies, threads and posts in 1999 and 2000 when the bubble burst.
Just about everyone thought their particular penny stock company was the next Microsoft.
Needless to say most of the companies aren't even around here.
I don't think this is the case with actc, but some of you folks are looking at things with rose colored glasses only like nothing could go wrong here, and that the sky is the limit.
TThe current stock price reflects the currently reality-hopefully that reality will change for the better.
I'm hoping we can hold out against a Big Pharma buyout too, since they quite likely have a host of researchers ready to reduce any possible cure or long term treatment we might come up with, into a daily dose.
Why a butout? It is possible that big pharma recognizes that the stem industry could become direct competition.
Surely big pharma is acutely aware of the time, effort and $$ needed to create a maintainence/lifestyle drug that enjoys temporary ptent protection. This identify, create, test, gain patent is a process that primarily provides maintenance and not correction.
It may be that big pharma could more benefit from strategic alliances with stem companies whose portfolio of competencies align with the resources big pharma possesses.
It may not take much to create a trend where big pharma and bio-techs ally to prospect and deliver stem corrections rather than develop the current array of temporarily protected/popular maintenance products.
In view of the uncertainties surrounding this company and the industry in general(the stock price is around $.08 for a reason), personally I feel someone would be nuts NOT to sell their holdings at $2.00 a share.
I myself hold over a million shares, and if the stock price even went to %.50, I would unload at least 50% of my shares and probably more without batting an eyelash.
I have been investing for 40 years, and the fact of the matter is the overwhelming majority of penny stocks(thats what this is no matter how one wants to spin it)go bellyup.
I think most folks would be elated just to see it go back to old highs and for most even $.20 would seem huge right now. jmho
Didn't you fear as you were buying over a million shares that actc a penny sock would go belly up?I mean now they are on the bink of long term success and you'll sell half your shares when the news is good.
Personally I would use my skills as a trader to take bites out and hopefully get more shares as time passes on way to selling out at maybe $55.00 a share :)
IT WILL HAVE PULLBACKS ON DAH WAY...
ACTC LONG n PATIENT
I think most of us shareholders would not object to being bought out at 2 or 3 or 5 bucks. However, I am sure our Board of Directors will do everything possible to defend the company from a buyout.